{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-27T21:00:12.310286+00:00","published_at":"2026-10-27T16:21:05.997386+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1wzdpd61uqfnuc","event_type":"DIRECTOR_APPOINTED","effective_at":"2026-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:robert-a-lenz-m-d-ph-d","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Robert A. Lenz, M.D., Ph.D. seat on LB PHARMACEUTICALS INC, effective 2026-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cdunl4se0d7a","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:rekha-hemrajani","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Rekha Hemrajani seat on LB PHARMACEUTICALS INC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1uwlnvn1goubqt","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:william-kane","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"William Kane seat on LB PHARMACEUTICALS INC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zu0sug15lb51i","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:committee:lb-pharmaceuticals-inc:audit-chair-compensation","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Audit · Chair; Compensation committee of LB PHARMACEUTICALS INC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1qmul7vji64lx","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:rekha-hemrajani","alpha:committee:lb-pharmaceuticals-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Rekha Hemrajani member of Audit · Chair; Compensation, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bujrt41iwsea2","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:heather-turner","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Heather Turner seat on LB PHARMACEUTICALS INC, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1w6lkmn16369ab","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:scott-garland","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Scott Garland seat on LB PHARMACEUTICALS INC, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8dn7f91plh7v3","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:committee:lb-pharmaceuticals-inc:audit-compensation-chair","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Audit; Compensation · Chair committee of LB PHARMACEUTICALS INC, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9px6os188q9o8","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:scott-garland","alpha:committee:lb-pharmaceuticals-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Scott Garland member of Audit; Compensation · Chair, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wjxd1e5ewoqa","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:ran-nussbaum","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Ran Nussbaum seat on LB PHARMACEUTICALS INC, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1syainlhx0bav","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:rebecca-luse","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Rebecca Luse seat on LB PHARMACEUTICALS INC, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rl39tm1nn18xg","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:ran-nussbaum","alpha:committee:lb-pharmaceuticals-inc:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:committee_record:21"],"evidence_ids":["alpha:projection-evidence:59ae8a63f3e171d537ff97562c7ee1e359980d815ec290542985f66664fb7936"],"summary":"Ran Nussbaum member of Nominating and Governance, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ml2e0v1iltywb","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:committee:lb-pharmaceuticals-inc:nominating-and-governance-chair","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Nominating and Governance · Chair committee of LB PHARMACEUTICALS INC, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:12pu8wp232utn","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:rebecca-luse","alpha:committee:lb-pharmaceuticals-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Rebecca Luse member of Nominating and Governance · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ihybkkijdmm4","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-27T16:21:05.997386+00:00","subject_ids":["alpha:person:robert-r-ruffolo-jr-ph-d-d-sc-d-eng-f-c-p-p","alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc"],"caused_claim_ids":["alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320"],"summary":"Robert R. Ruffolo, Jr., Ph.D., D.Sc., D.Eng., F.C.P.P. seat on LB PHARMACEUTICALS INC, effective 2019-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:5","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:heather-turner","object_label":"Heather Turner","object_source_name_forms":[],"value":"Heather Turner: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:heather-turner","name":"Heather Turner"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:6","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ran-nussbaum","object_label":"Ran Nussbaum","object_source_name_forms":[],"value":"Ran Nussbaum: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ran-nussbaum","name":"Ran Nussbaum"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:7","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rebecca-luse","object_label":"Rebecca Luse","object_source_name_forms":[],"value":"Rebecca Luse: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rebecca-luse","name":"Rebecca Luse"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:8","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rekha-hemrajani","object_label":"Rekha Hemrajani","object_source_name_forms":[],"value":"Rekha Hemrajani: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rekha-hemrajani","name":"Rekha Hemrajani"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:9","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-a-lenz-m-d-ph-d","object_label":"Robert A. Lenz, M.D., Ph.D.","object_source_name_forms":[],"value":"Robert A. Lenz, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robert-a-lenz-m-d-ph-d","name":"Robert A. Lenz, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2026-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-01-01","valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2026-01-01","effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:10","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-r-ruffolo-jr-ph-d-d-sc-d-eng-f-c-p-p","object_label":"Robert R. Ruffolo, Jr., Ph.D., D.Sc., D.Eng., F.C.P.P.","object_source_name_forms":[],"value":"Robert R. Ruffolo, Jr., Ph.D., D.Sc., D.Eng., F.C.P.P.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robert-r-ruffolo-jr-ph-d-d-sc-d-eng-f-c-p-p","name":"Robert R. Ruffolo, Jr., Ph.D., D.Sc., D.Eng., F.C.P.P."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:11","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:scott-garland","object_label":"Scott Garland","object_source_name_forms":[],"value":"Scott Garland: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:scott-garland","name":"Scott Garland"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:leadership_role:12","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:william-kane","object_label":"William Kane","object_source_name_forms":[],"value":"William Kane: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:william-kane","name":"William Kane"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc:committee_record:21","subject_id":"alpha:company:9169fd39-6d9e-46a0-9224-a2bf4b7df7bc","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Rebecca Luse; Members Rebecca Luse (Chair); Ran Nussbaum; Zachary Prensky","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Rebecca Luse","members":[{"display_name":"Rebecca Luse","person_slug":"rebecca-luse","is_chair":true},{"display_name":"Ran Nussbaum","person_slug":"ran-nussbaum","is_chair":false},{"display_name":"Zachary Prensky","person_slug":"zachary-prensky","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-27T16:21:05.997386+00:00","sources":[{"id":"alpha:projection-evidence:59ae8a63f3e171d537ff97562c7ee1e359980d815ec290542985f66664fb7936","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:0b4e3f9c7f2a94809588a4bcc3eb2b000e74218cd6bdc538c61f0aa8858ac320","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"LB PHARMACEUTICALS INC DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:30:21.369+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:59ae8a63f3e171d537ff97562c7ee1e359980d815ec290542985f66664fb7936","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526173679/d92245ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.832,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.892,"cross_source_agreement":0.75,"temporal_completeness":0.471},"diagnostics":{"published_claims":24,"factual_claims":24,"claims_with_linked_evidence":24,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-27T16:21:05.997386+00:00","observed_at":"2026-10-27T16:21:05.997386+00:00","reviewed_at":"2026-10-27T16:21:05.997386+00:00","verified_at":"2026-10-27T16:21:05.997386+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":24,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/lb-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/lb-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}